Skip to search formSkip to main contentSkip to account menu

everolimus 5 MG Oral Tablet [Afinitor]

Known as: Afinitor 5 MG Oral Tablet 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Background: Everolimus (Afinitor®) plus exemestane are indicated for hormone receptor-positive, HER2/neu-negative metastatic… 
Review
2012
Review
2012
Well-differentiated neuroendocrine tumors (NETs) can be subdivided into carcinoid and pancreatic NETs (panNETs). Recently, two… 
Review
2011
Review
2011
  • R. Amato
  • Expert opinion on pharmacotherapy
  • 2011
  • Corpus ID: 19475319
Introduction: The efficacy of sequential everolimus (RAD001, Afinitor®), an orally administered inhibitor of mammalian target of… 
Review
2009
Review
2009
ZusammenfassungDie letzten 5 Jahre waren durch grundlegende Veränderungen in der Systemtherapie des metastasierten…